Recent Insights » David Forster » The 21st Century Cures Act Easily Passed, But is it Good for Research Protection?
Other content in this Stream
Trend: Genetic Testing and Data Privacy Ownership
Understanding the Revised Common Rule
A Discussion of the Revised Common Rule - Jan 2017
Addressing the Challenges of Human Tissues and Cell Products Regulation
The 21st Century Cures Act: Implications for Human Subjects
Under the Microscope - Biomarker and Diagnostic Tests as FDA-Regulated Devices